NIH-funded research R01 grant

Understanding how alcohol affects cell behavior during jaw development

Official title: An ethanol-sensitive, Bmp-PCP dependent pathway regulating endoderm cell behaviors

Funded at University of Louisville · NIH-11087611 · Data updated 2026-11-12

This study looks at how alcohol affects the growth of the jaw in baby fish and how genes play a role in this process, hoping to find helpful information for preventing and treating issues related to Fetal Alcohol Spectrum Disorders in humans.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startMay 15, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$502,152
NIH project number5R01AA031043-02
Project IDNIH-11087611 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals affected by Fetal Alcohol Spectrum Disorders or those with a family history of alcohol-related developmental issues.

Less likely to help

Patients who do not have any history of alcohol exposure or related developmental concerns may not benefit from this research.

What this research studies

This research investigates the effects of ethanol on the development of the jaw in embryos, particularly focusing on how genetic factors influence these processes. Using zebrafish as a model, the study examines the role of Bone Morphogenetic Protein (Bmp) and Wnt/Planar Cell Polarity (PCP) signaling pathways in regulating cell movements and adhesion during jaw formation. By understanding these cellular interactions, the research aims to uncover the mechanisms behind developmental defects associated with Fetal Alcohol Spectrum Disorders (FASD). Patients may benefit from insights that could lead to better prevention and treatment strategies for conditions related to alcohol exposure during pregnancy.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and management of developmental defects caused by alcohol exposure during pregnancy.

How similar studies have gone: Previous research has shown success in using zebrafish models to study developmental defects, indicating that this approach is promising.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Lovely, Charles Benjamin — University of Louisville
  • Study coordinator: Lovely, Charles Benjamin

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.